XML 40 R17.htm IDEA: XBRL DOCUMENT v3.25.4
Supplementary Information
 12 Months Ended
Dec. 31, 2025
Supplementary Information [Abstract]  
Additional Financial Information Disclosure [Text Block] SUPPLEMENTARY INFORMATION
Other Income (Expense) - NetFor the Year Ended December 31,
(In millions)202520242023
Interest income$136 $132 $283 
Equity in earnings (losses) of affiliates - net13 15 10 
Net gain (loss) on sales of businesses and other assets41 17 22 
Net exchange gains (losses) 1
(181)(284)(397)
Non-operating pension and other post-employment benefit credits (costs) 2
(23)(144)(119)
Miscellaneous income (expenses) - net 3
(556)(36)(247)
Other income (expense) - net$(570)$(300)$(448)
1.    Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.
2.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
3.    Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2025 includes a charge related to the Bayer resolution offset by the receipt of insurance proceeds. The year ended December 31, 2024 includes the receipt of insurance proceeds and an indemnification payment negotiated with the prior Stoller owners. The years ended December 31, 2024 and 2023 also include estimated settlement reserves. The year ended December 31, 2023 also includes an Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on significant items.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States, whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
For the Year Ended December 31,
(In millions)202520242023
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(254)$(152)$(371)
Local tax (expenses) benefits 11 11 55 
Net after-tax impact from subsidiary exchange gain (loss) $(243)$(141)$(316)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)$73 $(132)$(26)
Tax (expenses) benefits(8)26 7 
Net after-tax impact from hedging program exchange gain (loss) $65 $(106)$(19)
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(181)$(284)$(397)
Tax (expenses) benefits3 37 62 
Net after-tax exchange gain (loss) $(178)$(247)$(335)
Noncontrolling interest adjustment— 1 — 
Net after-tax exchange gain (loss) attributable to Corteva$(178)$(246)$(335)

Cash, Cash Equivalents and Restricted Cash Equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.

(In millions)December 31, 2025December 31, 2024
Cash and cash equivalents$4,521 $3,106 
Restricted cash equivalents204 316 
Total cash, cash equivalents and restricted cash equivalents$4,725 $3,422 

Restricted cash equivalents primarily relates to a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. During the second quarter of 2024, the company's previously-restricted cash in the Water District Settlement Fund, which was established by Corteva, EIDP, Inc., DuPont and Chemours in September 2023 under the Nationwide Water District Settlement, was released. All of the company's restricted cash equivalents are classified as current as of December 31, 2025 and 2024, except for the $15 million MOU Escrow Account balance at December 31, 2024.

Accounts Payable
Accounts payable was $4,398 million and $4,039 million at December 31, 2025 and 2024, respectively. Accounts payable - trade, which is a component of accounts payable, was $2,871 million and $2,632 million at December 31, 2025 and 2024, respectively. Included in accounts payable – trade was seed grower compensation of approximately $420 million and $410 million at December 31, 2025 and 2024, respectively, which is measured at fair value using Level 2 inputs. Accrued discounts and rebates, which is a component of accounts payable, was $1,328 million and $1,207 million at December 31, 2025 and 2024, respectively. No other components of accounts payable were more than five percent of total current liabilities.